CDXC: ChromaDex Corporation Stock

by  •  • Comments Off on CDXC: ChromaDex Corporation Stock

SIC 2833 – Medicinal Chemicals and Botanical Products

Valuation
Market Cap ($M) 299.64
Enterprise Value ($M) 272.47
Book Value ($M) 28.46
Book Value / Share 0.38
Price / Book 10.53
NCAV ($M) 23.03
NCAV / Share 0.31
Price / NCAV 13.01

Profitability (mra)
Return on Invested Capital (ROIC) -0.16
Return on Assets (ROA) -0.09
Return on Equity (ROE) -0.18

Liquidity (mrq)
Quick Ratio 1.70
Current Ratio 2.40

Balance Sheet (mrq) ($M)
Current Assets 49.53
Assets 54.96
Liabilities 26.51
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 83.57
Operating Income -5.60
Net Income -4.94
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 7.12
Cash from Investing -0.14
Cash from Financing -0.09

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
09-07 13D/A Champion River Ventures Ltd 15.21 43.67

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-06 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTI
2023-11-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 Commission File Number: 001-
2023-08-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 Commission File Number: 001-37752
2023-05-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 Commission File Number: 001-3775

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-18 31,119 193,161 16.11
2024-04-17 36,075 68,246 52.86
2024-04-16 20,082 72,343 27.76
2024-04-15 24,023 67,485 35.60

(click for more detail)

Similar Companies
CDIO – Cardio Diagnostics Holdings, Inc. CDMO – Avid Bioservices, Inc.
CDTX – Cidara Therapeutics, Inc. CELU – Celularity Inc.
CELZ – Creative Medical Technology Holdings, Inc.


Financial data and stock pages provided by
Fintel.io